Oncocur Limited is a nano drug discovery company based in London, develops cost effective novel nano drug targets for anti-cancer. Our nanoparticle drug targets offers better efficacy by selective targeting, minimal drug toxicity and greater intracellular availability. Oncocur endeavours these life changing nanomedicine based therapeutic interventions available to the patients.